Merit Medical Systems, Inc. designs, develops, manufactures, and markets various disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides various peripheral intervention products, including access, angiography, intervention, and drainage and biopsy products to alleviate patients suffering from peripheral vascular and non-vascular diseases; and cardiac intervention products to aid in the treatment of various cardiac conditions specific to interventional cardiology and electrophysiology, including cardiac rhythm management and lead management. The company also offers cardiovascular and critical care products comprising infection prevention and safety, and fluid management and monitoring devices. In addition, it provides interventional oncology and spine products, such as vertebral compression fractures; tumor ablation systems; inflation syringes; microspheres for treating hypervascularized tumors and liver cancer; polyvinyl alcohol particles to treat hypervascularized tumors; and microcatheters for the controlled and selective infusion of diagnostic, embolic, or therapeutic agents into vessels. Further, the company offers endoscopy products, such as non-vascular stents, esophageal stents, biliary stent systems, esophageal balloon dilators, inflation devices, and guide wires; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; and microelectromechanical systems sensor components. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:MMSI
Previous Symbol
CUSIP58988910
Phone801-253-1600
Debt
Debt-to-Equity Ratio0.20
Current Ratio2.77
Quick Ratio1.47
Price-To-Earnings
Trailing P/E Ratio47.88
Forward P/E Ratio36.92
P/E Growth2.83
Sales & Book Value
Annual Sales$727.85 million
Price / Sales4.62
Cash Flow$2.3587 per share
Price / Cash25.98
Book Value$13.47 per share
Price / Book4.55
Profitability
EPS (Most Recent Fiscal Year)$1.28
Net Income$27.52 million
Net Margins4.72%
Return on Equity10.86%
Return on Assets6.55%
Miscellaneous
Employees4,876
Outstanding Shares54,830,000
Market Cap$3.36 billion
OptionableOptionable
Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions
What is Merit Medical Systems' stock symbol?
Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."
How were Merit Medical Systems' earnings last quarter?
Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its quarterly earnings results on Thursday, October, 25th. The medical instruments supplier reported $0.47 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.42 by $0.05. The medical instruments supplier had revenue of $221.66 million for the quarter, compared to analysts' expectations of $217.62 million. Merit Medical Systems had a return on equity of 10.86% and a net margin of 4.72%. View Merit Medical Systems' Earnings History.
When is Merit Medical Systems' next earnings date?
What price target have analysts set for MMSI?
9 brokerages have issued 12 month price targets for Merit Medical Systems' shares. Their predictions range from $58.00 to $79.00. On average, they expect Merit Medical Systems' stock price to reach $68.4444 in the next twelve months. This suggests a possible upside of 11.7% from the stock's current price. View Analyst Price Targets for Merit Medical Systems.
What is the consensus analysts' recommendation for Merit Medical Systems?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 sell rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Merit Medical Systems.
Has Merit Medical Systems been receiving favorable news coverage?
Media headlines about MMSI stock have been trending positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Merit Medical Systems earned a news impact score of 2.2 on InfoTrie's scale. They also assigned media stories about the medical instruments supplier a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the stock's share price in the near term.
Who are some of Merit Medical Systems' key competitors?
Some companies that are related to Merit Medical Systems include DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), Haemonetics (HAE), Globus Medical (GMED), ICU Medical (ICUI), Insulet (PODD), Penumbra (PEN), Integra Lifesciences (IART), Cantel Medical (CMD), NuVasive (NUVA), Novocure (NVCR), Glaukos (GKOS), Tandem Diabetes Care (TNDM) and Irhythm Technologies (IRTC).
Who are Merit Medical Systems' key executives?
Merit Medical Systems' management team includes the folowing people:
- Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 68)
- Mr. Ronald A. Frost, Chief Operating Officer (Age 56)
- Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 57)
- Mr. Joseph C. Wright, Pres of International Division (Age 48)
- Mr. Raul Parra Jr., CPA, Chief Financial Officer
Who are Merit Medical Systems' major shareholders?
Merit Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.59%), Dimensional Fund Advisors LP (3.78%), Eagle Asset Management Inc. (3.74%), Partner Fund Management L.P. (2.46%), Point72 Asset Management L.P. (2.46%) and Janus Henderson Group PLC (2.26%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower, Nolan E Karras, Richard W Edelman and Ronald Frost. View Institutional Ownership Trends for Merit Medical Systems.
Which major investors are selling Merit Medical Systems stock?
MMSI stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, JPMorgan Chase & Co., JPMorgan Chase & Co., Royce & Associates LP, Man Group plc, Partner Fund Management L.P., Perceptive Advisors LLC and Eagle Boston Investment Management Inc.. Company insiders that have sold Merit Medical Systems company stock in the last year include F Ann Millner, Franklin J Miller, Joseph Wright, Justin J Lampropoulos, Kent W Stanger, Michael E Stillabower and Ronald Frost. View Insider Buying and Selling for Merit Medical Systems.
Which major investors are buying Merit Medical Systems stock?
MMSI stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BlackRock Inc., Peregrine Capital Management LLC, Kornitzer Capital Management Inc. KS, Thrivent Financial for Lutherans, Castleark Management LLC, Putnam Investments LLC and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for Merit Medical Systems.
How do I buy shares of Merit Medical Systems?
Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Merit Medical Systems' stock price today?
One share of MMSI stock can currently be purchased for approximately $61.28.
How big of a company is Merit Medical Systems?
Merit Medical Systems has a market capitalization of $3.36 billion and generates $727.85 million in revenue each year. The medical instruments supplier earns $27.52 million in net income (profit) each year or $1.28 on an earnings per share basis. Merit Medical Systems employs 4,876 workers across the globe.
What is Merit Medical Systems' official website?
How can I contact Merit Medical Systems?
Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]
MarketBeat Community Rating for Merit Medical Systems (NASDAQ MMSI)
MarketBeat's community ratings are surveys of what our community members think about Merit Medical Systems and other stocks. Vote "Outperform" if you believe MMSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
